Category: Latest News
-
Microsoft Stock Hits New Record High at $508.40
Microsoft Corporation (NASDAQ:MSFT) achieved a significant milestone as its stock soared to an all-time high of $508.40. With a market value now at $3.77 trillion, the tech giant continues to assert its dominance in the industry. Over the past year, Microsoft’s stock has delivered a total return of 14.88%, fueled by impressive revenue growth of…
-
Caterpillar Stock Surges to Record High of $418.54
Shares of Caterpillar Inc. (NYSE:CAT) climbed to a new all-time peak at $418.54, marking a major milestone for the industrial equipment leader. With a market cap now standing at $196.4 billion, Caterpillar’s stock has gained 17.34% over the past year, reflecting the company’s strong footing in a competitive sector. Investor confidence is evident, supported by…
-
Oracle Shares Hit Record High at $242.45
Oracle Corporation (NYSE:ORCL) recently surged to an all-time stock price high of $242.45, pushing its market capitalization past $677 billion. This achievement highlights the company’s impressive growth, with its share price climbing nearly 75% over the past year. Oracle’s success is largely driven by strategic investments in cloud computing and enterprise software, which have garnered…
-
Waymo Broadens Its Self-Driving Service Area in Austin to 90 Square Miles
Alphabet’s Waymo (NASDAQ:GOOGL) is significantly increasing the coverage of its autonomous vehicle service in Austin, Texas, expanding from 37 to 90 square miles, the company revealed on Thursday. This expansion is designed to bolster Waymo’s foothold in the Austin market amid rising competition from players like Tesla (NASDAQ:TSLA). The newly included service zones now cover…
-
reAlpha Tech Shares Slide After Deeply Discounted $2M Offering
Shares of reAlpha Tech Corp. (NASDAQ:AIRE) plunged 25.7% after the real estate-focused AI company announced a public offering expected to raise $2 million in gross proceeds. The offering includes 13.3 million shares of common stock priced at $0.15 per share, along with Series A-1 and Series A-2 warrants that could enable investors to purchase an…
-
Oklo Stock Gains After Clearing Key Regulatory Hurdle for Aurora Project
Shares of Oklo Inc. (NYSE:OKLO) rose 2.5% after the company announced it has successfully completed the U.S. Nuclear Regulatory Commission’s (NRC) pre-application readiness assessment for its first commercial Aurora powerhouse. The NRC found no major deficiencies in Phase 1 of Oklo’s combined license application (COLA) for the proposed facility at Idaho National Laboratory, signaling that…
-
Bitmine Stock Rises as Ethereum Holdings Surpass $1 Billion
Shares of Bitmine Immersion Technologies Inc. (AMEX:BMNR) climbed 7.5% after the company disclosed that its Ethereum (ETH) holdings have exceeded $1 billion in value. As of July 17 at 3:45 a.m. ET, Bitmine reported holding 300,657 ETH at a market price of $3,461.89 per token. The milestone comes just a week after the company completed…
-
Webull Shares Gain on Plans to Relaunch Crypto Trading in U.S.
Webull Corporation (NASDAQ:BULL) shares rose 4% on Wednesday after the company announced plans to resume cryptocurrency trading in the United States during the third quarter as part of a broader restructuring. The online brokerage said it will reintegrate Webull Pay LLC into the core Webull group, consolidating its crypto operations under one structure. The move…
-
U.S. Stocks Edge Higher on Strong Retail Sales; Netflix Earnings in Focus
U.S. equities nudged higher on Thursday, supported by upbeat retail sales data and a wave of corporate earnings. As of 9:35 a.m. ET, the Dow Jones Industrial Average was up 100 points, or 0.2%, while the S&P 500 rose 4 points (0.1%) and the NASDAQ Composite gained 20 points (0.1%). Netflix Earnings Ahead Investor sentiment…
-
Rocket Pharmaceuticals Shares Jump After FDA Grants Accelerated Review Status to Gene Therapy
Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) surged 15% after receiving a key regulatory boost from the U.S. Food and Drug Administration (FDA), which granted its investigational gene therapy RP-A601 the Regenerative Medicine Advanced Therapy (RMAT) designation. The therapy is being developed to treat PKP2-arrhythmogenic cardiomyopathy (PKP2-ACM), a rare and potentially fatal inherited heart condition associated with arrhythmias…